| MIF as a glucocorticoid-induced modulator of cytokine production T Calandra, J Bernhagen, CN Metz, LA Spiegel, M Bacher, T Donnelly, ... Nature 377 (6544), 68-71, 1995 | 1488 | 1995 |
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites R Abe, SC Donnelly, T Peng, R Bucala, CN Metz The Journal of Immunology 166 (12), 7556-7562, 2001 | 1404 | 2001 |
| Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis H Wang, H Liao, M Ochani, M Justiniani, X Lin, L Yang, Y Al-Abed, ... Nature medicine 10 (11), 1216-1221, 2004 | 1384 | 2004 |
| MIF signal transduction initiated by binding to CD74 L Leng, CN Metz, Y Fang, J Xu, S Donnelly, J Baugh, T Delohery, Y Chen, ... The Journal of experimental medicine 197 (11), 1467-1476, 2003 | 1298 | 2003 |
| Protection from septic shock by neutralization of macrophage migration inhibitory factor T Calandra, B Echtenacher, DL Roy, J Pugin, CN Metz, L Hültner, ... Nature medicine 6 (2), 164-170, 2000 | 1031 | 2000 |
| An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct M Abe, JG Harpel, CN Metz, I Nunes, DJ Loskutoff, DB Rifkin Analytical biochemistry 216 (2), 276-284, 1994 | 961 | 1994 |
| An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. M Bacher, CN Metz, T Calandra, K Mayer, J Chesney, M Lohoff, D Gemsa, ... Proceedings of the National Academy of Sciences 93 (15), 7849-7854, 1996 | 897 | 1996 |
| Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell … RA Mitchell, CN Metz, T Peng, R Bucala Journal of Biological Chemistry 274 (25), 18100-18106, 1999 | 642 | 1999 |
| Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation RW Saeed, S Varma, T Peng-Nemeroff, B Sherry, D Balakhaneh, ... The Journal of experimental medicine 201 (7), 1113-1123, 2005 | 611 | 2005 |
| Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome SC Donnelly, C Haslett, PT Reid, IS Grant, WAH Wallace, CN Metz, ... Nature medicine 3 (3), 320-323, 1997 | 586 | 1997 |
| Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β I Nunes, PE Gleizes, CN Metz, DB Rifkin The Journal of cell biology 136 (5), 1151-1163, 1997 | 515 | 1997 |
| Advanced glycation end products and endothelial dysfunction in type 2 diabetes KCB Tan, WS Chow, VHG Ai, C Metz, R Bucala, KSL Lam Diabetes care 25 (6), 1055-1059, 2002 | 484 | 2002 |
| Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes J Chesney, C Metz, AB Stavitsky, M Bacher, R Bucala The Journal of Immunology 160 (1), 419-425, 1998 | 478 | 1998 |
| The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction E Rosengren, R Bucala, P Åman, L Jacobsson, G Odh, CN Metz, ... Molecular medicine 2 (1), 143-149, 1996 | 447 | 1996 |
| Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids M Leech, C Metz, P Hall, P Hutchinson, K Gianis, M Smith, H Weedon, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 445 | 1999 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 440 | 2021 |
| High expression of inducible 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (iPFK-2; PFKFB3) in human cancers T Atsumi, J Chesney, C Metz, L Leng, S Donnelly, Z Makita, R Mitchell, ... Cancer research 62 (20), 5881-5887, 2002 | 418 | 2002 |
| An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma J Chesney, C Metz, M Bacher, T Peng, A Meinhardt, R Bucala Molecular Medicine 5 (3), 181-191, 1999 | 412 | 1999 |
| ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis Y Al-Abed, D Dabideen, B Aljabari, A Valster, D Messmer, M Ochani, ... Journal of Biological Chemistry 280 (44), 36541-36544, 2005 | 388 | 2005 |
| Migration inhibitory factor expression in experimentally induced endotoxemia. M Bacher, A Meinhardt, HY Lan, W Mu, CN Metz, JA Chesney, T Calandra, ... The American journal of pathology 150 (1), 235, 1997 | 388 | 1997 |
